文献速递关节外科

术前阿片类药物使用对全膝关节置换术结局的影响

Impact of Preoperative Opioid Use on Total Knee Arthroplasty Outcomes.
PubMed 文献 · J Bone Joint Surg Am · 2017-01-01

该研究基于前瞻性队列数据,比较术前使用与未使用阿片类药物的全膝关节置换术(TKA)患者术后6个月的疼痛缓解情况。结果显示,阿片组WOMAC疼痛评分平均降低27.0分,非阿片组降低33.6分(p=0.008),提示术前使用阿片类药物者术后疼痛缓解较差。作者认为临床医生应考虑限制TKA术前阿片类药物处方以优化手术获益。

要点

  • 术前使用阿片类药物的TKA患者术后6个月疼痛缓解程度低于未使用者。
  • 调整倾向评分和基线疼痛后,阿片组WOMAC疼痛评分降低27.0分,非阿片组降低33.6分(p=0.008)。
  • 作者建议临床医生考虑限制TKA术前阿片类药物处方以优化手术获益。

核心结论

  • 术前使用阿片类药物的患者从TKA中获得的疼痛缓解较少。
  • 临床医生应考虑限制TKA术前阿片类药物处方以优化TKA的获益。

研究设计与样本

  • 研究为前瞻性队列研究,纳入TKA患者,基线WOMAC疼痛评分≥20分(0-100分,100为最差),有随访数据且TKA前2年内未接受其他手术。
  • 队列共156例患者,平均年龄65.7岁(标准差8.2岁),平均体重指数31.1 kg/m²(标准差6.1 kg/m²),女性占62.2%。
  • 术前36例(23%)至少有过1次阿片类药物处方。
  • 基于疼痛灾难化量表评分、合并症和基线疼痛构建术前阿片类药物使用的倾向评分,采用一般线性模型调整倾向评分和基线疼痛进行比较。

主要发现

  • 非阿片组平均基线WOMAC疼痛评分为43.0分(标准差12.8),阿片组为46.9分(标准差15.7)(p=0.12)。
  • 阿片组术前平均疼痛灾难化量表评分高于非阿片组(15.5分 vs 10.7分,p=0.006)。
  • 调整分析显示,阿片组术后6个月WOMAC疼痛评分平均降低27.0分(95%CI 22.7至31.3),非阿片组降低33.6分(95%CI 31.4至35.9)(p=0.008)。

关键数值与推荐

  • 纳入标准:基线WOMAC疼痛评分≥20分(0-100分,100为最差),有随访数据,TKA前2年内未接受其他手术。
  • 术前阿片类药物使用定义为至少有过1次阿片类药物处方。
  • 证据等级:治疗性III级。

临床怎么用

  • 作者认为临床医生应考虑限制TKA术前阿片类药物处方以优化TKA的获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is growing concern about the use of opioids prior to total knee arthroplasty (TKA), and research has suggested that preoperative opioid use may lead to worse pain outcomes following surgery. We evaluated the pain relief achieved by TKA in patients who had and those who had not used opioids use before the procedure. METHODS: We augmented data from a prospective cohort study of TKA outcomes with opioid-use data abstracted from medical records. We collected patient-reported outcomes and demographic data before and 6 months after TKA. We used the Pain Catastrophizing Scale and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) to quantify the pain experiences of patients treated with TKA who had had a baseline score of ≥20 on the WOMAC pain scale (a 0 to 100-point scale, with 100 being the worst score), who provided follow-up data, and who had not had another surgical procedure within the 2 years prior to TKA. We built a propensity score for preoperative opioid use based on the Pain Catastrophizing Scale score, comorbidities, and baseline pain. We used a general linear model, adjusting for the propensity score and baseline pain, to compare the change in the WOMAC pain score 6 months after TKA between persons who had and those who had not used opioids before TKA. RESULTS: The cohort included 156 patients with a mean age of 65.7 years (standard deviation [SD] = 8.2 years) and a mean body mass index (BMI) of 31.1 kg/m (SD = 6.1 kg/m); 62.2% were female. Preoperatively, 36 patients (23%) had had at least 1 opioid prescription. The mean baseline WOMAC pain score was 43.0 points (SD = 12.8) for the group that had not used opioids before TKA and 46.9 points (SD = 15.7) for those who had used opioids (p = 0.12). The mean preoperative Pain Catastrophizing Scale score was greater among opioid users (15.5 compared with 10.7 points among non-users, p = 0.006). Adjusted analyses showed that the opioid group had a mean 6-month reduction in the WOMAC pain score of 27.0 points (95% confidence interval [CI] = 22.7 to 31.3) compared with 33.6 points (95% CI = 31.4 to 35.9) in the non-opioid group (p = 0.008). CONCLUSIONS: Patients who used opioids prior to TKA obtained less pain relief from the operation. Clinicians should consider limiting pre-TKA opioid prescriptions to optimize the benefits of TKA. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Smith SR, Bido J, Collins JE, et al. Impact of Preoperative Opioid Use on Total Knee Arthroplasty Outcomes. J Bone Joint Surg Am. 2017. PMID: 28509820. doi:10.2106/JBJS.16.01200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。